Warren Alpert Medical School of Brown University, Office of Continuing Medical Education and
Rhode Island Department of Health Academic Center


Benzodiazepines: Pharmacology to Co-Prescribing Risks and Concerns

Program Description
This five-part program will address the growing problem of benzodiazepine prescribing alone and in combination with other opioids. The program is targeted to prescribers of all controlled substances and designed to be a practical understanding of this topic as well as reminding prescribers of the pharmacological and epidemiological principles that underlay this issue. Upon completion of these modules, prescribers should change their prescribing habits to be more aligned with safer alternatives, which more appropriately address chronic conditions such as non-cancer pain, anxiety, and unique issues associated with the elderly.

This training meets the requirements set forth in RI Regulation 3.14 Prescriber Training Requirement for Best Practices Regarding Opioid Prescribing. This specific training requirement is required only once and must be completed before renewal of controlled substance registration or two (2) years (whichever is longer).  http://sos.ri.gov/rules/index.php?page=details&erlid=8473

Physicians, physician assistants, advanced practice pharmacists, APRNs, residents, & fellows who prescribe controlled substances.

Estimated Time to Complete each activity: between 60 and 90 minutes

View Activity    Issues in Benzodiazepine Pharmacology (90 min)
View Activity    Opioids and Benzodiazepines: An Overview of the Clinical Issues in Pain Management (60 min)
View Activity    The Role of Benzodiazepines in the Treatment of Anxiety (60 min)
View Activity   The Role of Benzodiazepines in the Elderly (60 min)
View Activity    Epidemiology of Benzodiazepine Prescribing in Rhode Island (75 min)

Release Date: September 30, 2016
Valid Through: September 30, 2018